NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin. |
2017-09-11 |
Evotec AG. (9/8/17). "Press Release: European Investment Bank Supports Evotec’s Innovate Strategy with EUR 75 M Loan". Hamburg & Brussels. |
2017-09-08 |
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. |
2017-09-08 |
Leap Therapeutics, Inc.. (9/8/17). "Press Release: Leap Therapeutics Announces Collaboration with EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers". Cambridge, MA. |
2017-09-08 |
Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. |
2017-09-08 |
Epigenomics AG. (9/8/17). "Press Release: Epigenomics AG Issues Convertible Bonds". Berlin & Germantown, MD. |
2017-09-08 |
Evotec AG. (9/7/17). "Press Release: Evotec and Abivax Enter into Strategic Collaboration to Develop Novel Antiviral Agents". Hamburg & Paris. |
2017-09-07 |
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Wins New Long-term Oriented Investor by Way of a Capital Increase. DAH Beteiligungs GmbH Is New, Long-term Oriented Investor of BRAIN AG Supporting Its Growth Strategy". Zwingenberg. |
2017-09-07 |
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Resolves Upon Capital Increase – New Long-term Investor Subscribes All New Shares [Ad-hoc News]". Zwingenberg. |
2017-09-07 |
Bayer AG. (9/7/17). "Press Release: Bayer Submits Marketing Authorization Application for BAY94-9027 for the Treatment of Hemophilia A in the EU [Not intended for U.S. and UK Media]". Berlin. |
2017-09-07 |
Boehringer Ingelheim. (9/7/17). "Press Release: Boehringer Ingelheim and Gubra Collaborate to Develop Next Generation Obesity Treatments". Ingelheim & Hørsholm. |
2017-09-07 |
Markes International Ltd.. (9/7/17). "Press Release: Markes International Opens New Chinese Subsidiary in Shanghai". |
2017-09-07 |
InflaRx GmbH. (9/7/17). "Press Release: InflaRx Reports Topline Phase IIa Clinical Results of IFX-1 for the Treatment of Hidradenitis Suppurativa". Jena. |
2017-09-07 |
MorphoMed GmbH. (9/7/17). "Press Release: MorphoMed – New Start-up Focusing on Next-generation Tissue Engineering in Vienna". |
2017-09-07 |
Merck & Co., Inc.. (9/6/17). "Press Release: Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology". Kenilworth, NJ & Munich. |
2017-09-06 |
Bruker Corporation. (9/6/17). "Press Release: Bruker Announces the New D8 Discover Plus XRD System". Chiba. |
2017-09-06 |
Metabolomic Discoveries GmbH. (9/5/17). "Press Release: Metabolon Acquires Metabolomic Discoveries GmbH". Research Triangle Park, NC. |
2017-09-05 |
Immunic AG. (9/5/17). "Press Release: Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million". Planegg-Martinsried. |
2017-09-05 |
Merck KGaA. (9/5/17). "Press Release: Merck Prepares Strategic Options for the Consumer Health Business. Important Step in Executing Science and Technology Focused Strategy". Darmstadt. |
2017-09-05 |
Amal Therapeutics S.A.. (9/5/17). "Press Release: Amal Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round". Geneva. |
2017-09-05 |
Phenomenex, Inc.. (9/5/17). "Press Release: Phenomenex Announces Direct Sales and Support in Switzerland". Torrance, CA. |
2017-09-05 |
Global Antibiotic Research and Development Partnership (GARDP). (9/4/17). "Press Release: More than EUR 56 Million Raised to Fund Initiative to Fight Antibiotic Resistance". Berlin. |
2017-09-04 |
Allcyte GmbH. (9/4/17). "Press Release: Allcyte Collaborates with Boehringer Ingelheim to Advance Preclinical Oncology Drug Discovery by Using Novel Drug Response Profiling Technology". Vienna. |
2017-09-04 |
Merck KGaA. (9/1/17). "Press Release: Successful Closing of Biosimilars Transaction". Darmstadt. |
2017-09-01 |
Merck KGaA. (9/1/17). "Press Release: Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci". Darmstadt. |
2017-09-01 |
Grünenthal GmbH. (9/1/17). "Press Release: Mark Fladrich Takes Office as the New CCO of the Grünenthal Group". Aachen. |
2017-09-01 |
Amcure GmbH. (8/31/17). "Press Release: Amcure Receives Additional €1.75M BMBF Research Grant". Eggenstein-Leopoldshafen. |
2017-08-31 |
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. |
2017-08-31 |
Eurofins Scientific. (8/30/17). "Press Release: Eurofins Reports Solid H1 2017 Results with 15.6% Revenue Growth on the Back of an Organic growth of about 6% and over 35 Acquisitions". |
2017-08-30 |
Evolva Holding S.A.. (8/30/17). "Press Release: Evolva Announces Major Restructuring for Next Phase of Its Development". |
2017-08-30 |
Merck KGaA. (8/30/17). "Press Release: Merck Opens Its First Customer Food Safety Studio". Darmstadt. |
2017-08-30 |
Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg. |
2017-08-30 |
Novartis AG. (8/30/17). "Press Release: Novartis Receives First Ever FDA Approval for a CAR-T Cell Therapy, Kymriah (CTL019), for Children and Young Adults with B-cell ALL that is Refractory or Has Relapsed at Least Twice". Basel. |
2017-08-30 |
Epigenomics AG. (8/30/17). "Press Release: Epigenomics Commences Post Approval Study on Epi proColon". Berlin & Germantown, MD. |
2017-08-30 |
Forge Therapeutics, Inc.. (8/29/17). "Press Release: Forge Therapeutics and Evotec to Present Preclinical Data on Novel Antibiotic Program at 2017 ASM/ESCMID Conference". San Diego, CA. |
2017-08-29 |
Merck KGaA. (8/29/17). "Press Release: Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy". Darmstadt. |
2017-08-29 |
Boehringer Ingelheim. (8/29/17). "Press Release: Boehringer Ingelheim Pharmaceuticals, Inc. Receives FDA Approval for Cyltezo (adalimumab-adbm), a Biosimilar to Humira, for the Treatment of Multiple Chronic Inflammatory diseases". Ingelheim & Ridgefield, |
2017-08-29 |
DBV Technologies S.A.. (8/29/17). "Press Release: DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut". Montrouge. |
2017-08-29 |
Thermo Fisher Scientific Inc.. (8/29/17). "Press Release: Thermo Fisher Scientific Completes Acquisition of Patheon". Waltham, MA. |
2017-08-29 |
Kite Pharma, Inc.. (8/28/17). "Press Release: Gilead Sciences to Acquire Kite Pharma for $11.9 Billion. Immediately Positions Gilead as a Leader in Cell Therapy". Foster City, CA & Santa Monica, CA. |
2017-08-28 |
European Invesmtent Bank (EIB). (8/28/17). "Press Release: Investment Plan for Europe – EIB Grants Financing to Apeiron". |
2017-08-28 |
Merck KGaA. (8/28/17). "Press Release: Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities". Darmstadt. |
2017-08-28 |
Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. |
2017-08-28 |
Mologen AG. (8/25/17). "Press Release: Mologen AG and Chinese iPharma Ltd. Signed Binding Term Sheet for a Collaboration Regarding the Development, Manufacture and Commercialization of Lefitolimod in China and a Potential Co-development". |
2017-08-25 |
Kiadis Pharma N.V.. (8/25/17). "Press Release: Kiadis Pharma Announces Financial Results for the Six Months ended June 30, 2017". Amsterdam-Duivendrecht. |
2017-08-25 |
Merck KGaA. (8/25/17). "Press Release: European Commission Grants Approval for Mavenclad (Cladribine Tablets)". Darmstadt. |
2017-08-25 |
Aurealis Pharma. (8/25/17). "Press Release: Aurealis Pharma Announces 5.6MCHF Series A Financing to Advance Chronic Wound and Oncology Lead Products". Basel & Kuopio. |
2017-08-25 |
Xoma Corporation. (8/25/17). "Press Release: Xoma Announces Transformational License Agreements for Gevokizumab and Its IL-1 beta Intellectual Property Portfolio". Berkeley, CA. |
2017-08-25 |
Novartis AG. (8/24/17). "Press Release: Novartis Appoints Bertrand Bodson as Chief Digital Officer". Basel. |
2017-08-24 |
Labfolder GmbH. (8/24/17). "Press Release: Labfolder Expands to North America and Initiates Collaboration with the German Accelerator Life Sciences". Berlin & Cambridge, MA. |
2017-08-24 |
Biogen Inc.. (8/24/17). "Press Release: Imraldi, Biogen’s Adalimumab Biosimilar Referencing Humira, Is Approved in the European Union". Zug. |
2017-08-24 |
Boehringer Ingelheim. (8/24/17). "Press Release: Boehringer Ingelheim Initiates Phase IIa Study of Compound Acquired from Pharmaxis in Debilitating Liver Disease NASH". Ingelheim & Sydney. |
2017-08-24 |
Roche. (8/24/17). "Press Release: FDA grants Priority Review to Roche’s Emicizumab for Haemophilia A with [Factor VIII] Inhibitors". Basel. |
2017-08-24 |
Novartis AG. (8/24/17). "Press Release: Novartis Kisqali (ribociclib) Receives EU Approval as First-line Treatment for HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Combination with any Aromatase Inhibitor". Basel. |
2017-08-24 |
Merck KGaA. (8/23/17). "Press Release: Merck Sets Up PMatX Incubator in Israel for Next-Generation Electronics". Darmstadt. |
2017-08-23 |
Macrophage Pharma Ltd.. (8/23/17). "Press Release: Macrophage Pharma Extends Series A Round to Include New Investor Merck Ventures". |
2017-08-23 |
Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. |
2017-08-23 |
AiCuris Anti-infective Cures GmbH. (8/23/17). "Press Release: AiCuris Announces Final Patient Treated in Clinical Phase 2 Trial (LipP 1) with Topical Pritelivir for the Treatment of Recurrent Labial Herpes". Wuppertal. |
2017-08-23 |
Denka Co. Ltd.. (8/23/17). "Press Release: Denka Completes the Acquisition of Icon Genetics GmbH, a German Bio-pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary". |
2017-08-23 |
Topas Therapeutics GmbH. (8/22/17). "Press Release: Topas Therapeutics Signs Multi-year Research and Option Agreement with Lilly Focused on Immune Tolerance". Hamburg. |
2017-08-22 |
Micro-Sphere S.A.. (8/22/17). "Press Release: CDMO to Invest €19m in GMP Facility Expansion". |
2017-08-22 |
CRISPR Therapeutics AG. (8/22/17). "Press Release: CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies". Zug & Cambridge, MA. |
2017-08-22 |
UGA Biopharma GmbH. (8/22/17). "Press Release: Collaboration between Batavia Biosciences and UGA Biopharma". |
2017-08-22 |
AC Immune S.A.. (8/22/17). "Press Release: AC Immune Discovers Next-generation Antibodies Focused on Neurodegenerative Diseases". Lausanne. |
2017-08-22 |
Bruker Corporation. (8/22/17). "Press Release: Bruker and Dectris Announce Advances in D8 X-ray Diffraction Systems with the New Eiger2 R 500K Detector". Hyderabad. |
2017-08-22 |
Immatics Biotechnologies GmbH. (8/21/17). "Press Release: Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse". Houston, TX & Tübingen. |
2017-08-21 |
Ethris GmbH. (8/21/17). "Press Release: Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies for Respiratory Diseases". Munich & Gaithersburg, MD. |
2017-08-21 |
Lumitos GmbH. (8/21/17). "Press Release: Chemie.DE Becomes Lumitos. Europe’s Leading Provider of B2B Portals Grows under a New Name with a Markedly Expanded Service Portfolio". Berlin. |
2017-08-21 |
Qiagen N.V.. (8/21/17). "Press Release: Qiagen and Clinical Genomics Partner on Liquid Biopsies to Monitor Patients for Recurrence of Colorectal Cancer". Hilden, Germantown, MD & Bridgewater, NJ. |
2017-08-21 |
Bruker Corporation. (8/21/17). "Press Release: Bruker Announces Novel D8 Venture BioTolls for Advanced Structural Biology Research by X-Ray Crystallography". Hyderabad. |
2017-08-21 |
Stada Arzneimittel AG. (8/18/17). "Press Release: Stada Takeover Offer by Bain Capital and Cinven Successful". Bad Vilbel. |
2017-08-18 |
High-Tech Gründerfonds Management GmbH. (8/18/17). "Press Release: Crowdfunding Triggers Capital Increase of 800,000 Euros at Rodos Biotarget". |
2017-08-18 |
Oxford Biomedica plc. (8/17/17). "Press Release: Interim Results for the Six Months Ended 30 June 2017". Oxford. |
2017-08-17 |
Analytik Jena AG. (8/17/17). "Press Release: TATAA Biocenter Expands its Real-time PCR Offerings with Analytik Jena´s qTOWER³". Gothenburg & Jena. |
2017-08-17 |
Mimetas B.V.. (8/16/17). "Press Release: Mimetas Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Pharmaceutical Company". Leiden. |
2017-08-16 |
Biotecon Diagnostics GmbH. (8/16/17). "Press Release: Biotecon Diagnostics GmbH Is Now an Official OEM Partner for the Distribution of Bruker MALDI-TOF MS Systems". Potsdam. |
2017-08-16 |
Monsanto Company. (8/16/17). "Press Release: Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers". St. Louis, MO & Seoul. |
2017-08-16 |
Evotec AG. (8/16/17). "Press Release: Evotec Completes Acquisition of Aptuit". Hamburg. |
2017-08-16 |
Mundipharma International Ltd.. (8/14/17). "Press Release: Mundipharma and CellAct Announce New Deal for the Worldwide Development and Commercialization of Smart Chemotherapy CAP7.1". |
2017-08-14 |
Evolva Holding S.A.. (8/14/17). "Press Release: Evolva Announces Financial Results for the First Half of 2017". |
2017-08-14 |
Bruker Corporation. (8/14/17). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. |
2017-08-14 |
Lyomark Pharma GmbH. (8/14/17). "Press Release: Lyomark Pharma GmbH Becomes Majority Shareholder of Lyocontract GmbH". |
2017-08-14 |
Evotec AG. (8/10/17). "Press Release: Evotec Announces First Half Year 2017 Results and Corporate Update". Hamburg. |
2017-08-10 |
Mologen AG. (8/10/17). "Press Release: Important Milestones Achieved in Clinical Trials during the First Half 2017". Berlin. |
2017-08-10 |
Pieris Pharmaceuticals, Inc.. (8/10/17). "Press Release: Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer". Boston, MA. |
2017-08-10 |
Basilea Pharmaceutica Ltd.. (8/10/17). "Press Release: Basilea Reports Improved Financial Results in Half-year 2017 Driven by Growing Product Sales, Significant Progress on Partnering and Development Programs". Basel. |
2017-08-10 |
Roivant Sciences GmbH. (8/9/17). "Press Release: Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund". Basel & London. |
2017-08-09 |
Mologen AG. (8/9/17). "Press Release: Results of the Extension Phase of the Exploratory Phase Ib/IIa Study in HIV". |
2017-08-09 |
Pieris Pharmaceuticals, Inc.. (8/9/17). "Press Release: Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update". Boston, MA. |
2017-08-09 |
Epigenomics AG. (8/9/17). "Press Release: Epigenomics AG Announces 2017 Second Quarter and Six Months Financial Results". Berlin & Germantown, MD. |
2017-08-09 |
AC Immune S.A.. (8/9/17). "Press Release: AC Immune Reports Second Quarter 2017 Financial Results". Lausanne. |
2017-08-09 |
Bruker Corporation. (8/8/17). "Press Release: Hungarian Ministry of Agriculture Selects Bruker NMR FoodScreener for Authentication and Identification of Hungarian Wines". Budapest. |
2017-08-08 |
Oxford Biomedica plc. (8/7/17). "Press Release: Oxford BioMedica Announces MHRA Licence For Commercial Supply". London. |
2017-08-07 |
Epigenomics AG. (8/7/17). "Press Release: Epigenomics AG – Notice of Loss Pursuant to § 92 par. 1 AktG". |
2017-08-07 |
KCR CRO GmbH. (8/7/17). "Press Release: KCR Expands Its European Services with a New Office in Leeds, UK". Berlin. |
2017-08-07 |
Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. |
2017-08-07 |
Lonza Group AG. (8/4/17). "Press Relase: Lonza Acquires Micro-Macinazione to Create the Global Leader in Micronization Capacity and Capabilities". Basel. |
2017-08-04 |
Lonza Group AG. (8/4/17). "Press Relase: Lonza Prices EUR 700 Million and USD 200 Million Multi Tranche »Schuldschein« Loan". Basel. |
2017-08-04 |
Bristol-Myers Squibb Company. (8/3/17). "Press Relase: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity". New York, NY & Boston, MA. |
2017-08-03 |
PerkinElmer, Inc.. (8/3/17). "Press Relase: PerkinElmer Announces Financial Results for the Second Quarter of 2017". Waltham, MA. |
2017-08-03 |